Antibiotic tigecycline inhibits cell proliferation, migration and invasion via down‐regulating CCNE2 in pancreatic ductal adenocarcinoma

Recently, many researches have reported that antibiotic tigecycline has significant effect on cancer treatment. However, biomedical functions and molecular mechanisms of tigecycline in human pancreatic ductal adenocarcinoma (PDAC) remain unclear. In the current study, we tried to assess the effect o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jie, Dong, Zhen, Ren, Aishu, Fu, Gang, Zhang, Kui, Li, Changhong, Wang, Xiangwei, Cui, Hongjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171345/
https://www.ncbi.nlm.nih.gov/pubmed/32141702
http://dx.doi.org/10.1111/jcmm.15086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171345/
https://www.ncbi.nlm.nih.gov/pubmed/32141702
http://dx.doi.org/10.1111/jcmm.15086

Ejemplares similares